Trials / Completed
CompletedNCT03475875
Contact Lenses With New UV-blocker Manufactured With Different Techniques
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is a randomized, 4-visit, double-masked, 2x3 bilateral crossover, dispensing trial. The study lenses will be worn as daily wear (DW) for a period of two weeks each with one of the study lenses being worn twice. Each study lens is expected to be worn at least five (5) days per week for at least six (6) hours per day worn. There will be no washout period between study lenses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | senofilcon A TEST Lens | senofilcon A with new UV blocker investigational process |
| DEVICE | senofilcon A CONTROL Lens | senofilcon A with new UV blocker standard process |
Timeline
- Start date
- 2018-02-19
- Primary completion
- 2018-04-18
- Completion
- 2018-04-18
- First posted
- 2018-03-23
- Last updated
- 2019-06-04
- Results posted
- 2019-06-04
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03475875. Inclusion in this directory is not an endorsement.